Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 10,000 shares at $25.65 ($257K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Scheduled sale ($256k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARQT | SELL | 2026-07-17 | $127K | — | Filing → |
| ARQT | SELL | 2026-06-17 | $116K | — | Filing → |
| ARQT | SELL | 2026-05-05 | $164K | — | Filing → |